本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zentalis Pharmaceuticals, LLC

1.42
-0.0100-0.70%
成交量:54.26万
成交额:78.06万
市值:1.02亿
市盈率:-0.61
高:1.54
开:1.44
低:1.41
收:1.43
数据加载中...
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/10/02

重要事件披露

8-K - Current report
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

重要事件披露

8-K - Current report
2020/07/31

重要事件披露

8-K - Current report
2020/07/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/27

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/07/02

重要事件披露

8-K - Current report
2020/05/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals